Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Roxane Khoogar, Ph.D., Ph.D.

Concepts (13)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Roxane Khoogar's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Roxane Khoogar has written about over time.
Antineoplastic Agents, 1 publications between 2016 and 2016, average publication date February 2016. Biological Products, 1 publications between 2016 and 2016, average publication date February 2016. Gastrointestinal Neoplasms, 1 publications between 2016 and 2016, average publication date February 2016. Signal Transduction, 1 publications between 2016 and 2016, average publication date February 2016. Small Molecule Libraries, 1 publications between 2016 and 2016, average publication date February 2016. Animals, 2 publications between 2016 and 2022, average publication date January 2019. Humans, 2 publications between 2016 and 2022, average publication date January 2019. Cell Line, Tumor, 1 publications between 2022 and 2022, average publication date January 2022. Down-Regulation, 1 publications between 2022 and 2022, average publication date January 2022. Mice, 1 publications between 2022 and 2022, average publication date January 2022. Oncogene Proteins, Fusion, 1 publications between 2022 and 2022, average publication date January 2022. RNA, 1 publications between 2022 and 2022, average publication date January 2022. RNA-Binding Protein EWS, 1 publications between 2022 and 2022, average publication date January 2022.

To see the data from this visualization as text, click here.
Khoogar's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (13)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.